1-7 of 7
Winnie Yeo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma

Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss, Thomas Yau, Paul Ross, Vincenzo Mazzaferro, Jean-Frédéric Blanc, Yuk Ting Ma, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gérolami, Jean-François Dufour, Edward J. Gane, Baek-Yeol Ryoo, Markus Peck-Radosavljevic, Thong Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Katrin Roth, Diego Reis, Barrett H. Childs, Heiko Krissel, Josep M. Llovet
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (19): 4650–4661.
https://doi.org/10.1158/1078-0432.CCR-17-3588
Published: 01 October 2018
View articletitled, Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Open the PDF for Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma in another window
Journal Articles

A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

Ho Yeong Lim, Jeong Heo, Hye Jin Choi, Cheng-Yao Lin, Jung-Hwan Yoon, Chiun Hsu, Kun-Ming Rau, Ronnie T.P. Poon, Winnie Yeo, Joong-Won Park, Miah Hiang Tay, Wen-Son Hsieh, Christian Kappeler, Prabhu Rajagopalan, Heiko Krissel, Michael Jeffers, Chia-Jui Yen, Won Young Tak
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 5976–5985.
https://doi.org/10.1158/1078-0432.CCR-13-3445
Published: 30 November 2014
View articletitled, A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma
Open the PDF for A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Intensive Hypermethylation of the CpG Island of Ras Association Domain Family 1A in Hepatitis B Virus-associated Hepatocellular Carcinomas

Sheng Zhong, Winnie Yeo, Mandy W. Tang, Nathalie Wong, Paul B. S. Lai, Phillip J. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3376–3382.
Published: 05 September 2003
View articletitled, Intensive Hypermethylation of the CpG Island of Ras Association Domain Family 1A in Hepatitis B Virus-associated Hepatocellular Carcinomas
Open the PDF for Intensive Hypermethylation of the CpG Island of Ras Association Domain Family 1A in Hepatitis B Virus-associated Hepatocellular Carcinomas in another window
Journal Articles

Silencing of GSTP1 Gene by CpG Island DNA Hypermethylation in HBV-associated Hepatocellular Carcinomas

Sheng Zhong, Mandy W. Tang, Winnie Yeo, Cuiling Liu, Y. M. Dennis Lo, Philip J. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1087–1092.
Published: 01 April 2002
View articletitled, Silencing of GSTP1 Gene by CpG Island DNA Hypermethylation in HBV-associated Hepatocellular Carcinomas
Open the PDF for Silencing of GSTP1 Gene by CpG Island DNA Hypermethylation in HBV-associated Hepatocellular Carcinomas in another window
Journal Articles

Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients

Ivy H. N. Wong, Y. M. Dennis Lo, Winnie Yeo, Wan Y. Lau, Philip J. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3516–3521.
Published: 01 September 2000
View articletitled, Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients
Open the PDF for Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients in another window
Journal Articles

Hematogenous Dissemination of Hepatocytes and Tumor Cells after Surgical Resection of Hepatocellular Carcinoma: A Quantitative Analysis

Ivy H. N. Wong, Wan Y. Lau, Thomas Leung, Winnie Yeo, Philip J. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4021–4027.
Published: 01 December 1999
View articletitled, Hematogenous Dissemination of Hepatocytes and Tumor Cells after Surgical Resection of Hepatocellular Carcinoma: A Quantitative Analysis
Open the PDF for Hematogenous Dissemination of Hepatocytes and Tumor Cells after Surgical Resection of Hepatocellular Carcinoma: A Quantitative Analysis in another window
Journal Articles

Complete Pathological Remission Is Possible with Systemic Combination Chemotherapy for Inoperable Hepatocellular Carcinoma

Thomas W. T. Leung, Yehuda Z. Patt, Wan-yee Lau, Stephen K. W. Ho, Simon C. H. Yu, Anthony T. C. Chan, Tony S. K. Mok, Winnie Yeo, Choong-tsek Liew, Nancy W. Y. Leung, Amanda M. Y. Tang, Philip J. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (7): 1676–1681.
Published: 01 July 1999
View articletitled, Complete Pathological Remission Is Possible with Systemic Combination Chemotherapy for Inoperable Hepatocellular Carcinoma
Open the PDF for Complete Pathological Remission Is Possible with Systemic Combination Chemotherapy for Inoperable Hepatocellular Carcinoma in another window